Parsifal Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.6M | Sell |
2,900,630
-1,301,557
| -31% | -$21.8M | 4.12% | 11 |
|
|
2025
Q1 | $64.6M | Sell |
4,202,187
-169,814
| -4% | -$2.61M | 5.59% | 6 |
|
|
2024
Q4 | $96.4M | Sell |
4,372,001
-1,860,970
| -30% | -$41M | 8.04% | 6 |
|
|
2024
Q3 | $112M | Sell |
6,232,971
-463,981
| -7% | -$8.36M | 7.68% | 5 |
|
|
2024
Q2 | $109M | Buy |
6,696,952
+1,648,652
| +33% | +$26.8M | 7.85% | 5 |
|
|
2024
Q1 | $71.2M | Buy |
+5,048,300
| New | +$71.2M | 4.92% | 10 |
|